Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2239-2026

HydroMARK Breast Biopsy Site Marker Recall

HydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3

FDA recall Class II

Ongoing

FDA lists this Class II recall for HydroMARK Breast Biopsy Site Marker. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2239-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 24, 2026
FDA report date
Jun 3, 2026
Quantity in commerce
1910 units
Distribution
See key details
FDA cause
Labeling mix-ups

What is being recalled?

HydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3

Affected model & UDI checker

Search the exact identifiers published for Z-2239-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
4010-02-15-T3HydroMARK Breast Biopsy Site MarkerCheck source noticeNot specified
FDA code information

Lot Number: F12607207D

View the original FDA recall notice

Why was this product recalled?

Incorrect inner package labeling. Boxes labeled 4010-02-15-T3 markers may contain individual packages labeled as T4 Markers.

What actions did Devicor Medical Products Inc take?

An URGENT FIELD SAFETY RECALL was sent to customers beginning 4/24/26. Action to be taken by the user: As a result of this notification, please conduct the following: "Examine your inventory and identify any devices from Lot F12607207D. "Immediately remove from use any devices labeled as 4010 02 15 T4 from this lot. "Contact your local sales representative to coordinate next steps. The affected product (devices labeled as4010 02 15 T4 from lot F12607207D) may either: -Be handed to a sales representative for removal, or -Be disposed of at your facility in accordance with local and institutional disposal requirements. "If a marker from this lot has already been implanted, review and update patient records as appropriate. "Complete and return the Recall Response Form (included with this notification), even if you no longer have affected product, to confirm the receipt of this notice and completion of required actions. If you have any additional questions, comments or concerns please contact our Customer Support at +1 877-926-2666. You may also email [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology